Mary M. Parkes Center for Asthma, Allergy and Pulmonary Care

Rochester, New York 14643

0 studies enrolling now · 3 studies all time

What they study most

Pulmonary Arterial Hypertension, Pulmonary Hypertension

Studies at this site

• FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
• Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects — Completed
• Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension — Completed